Search for Clinical Trial Results
Lichen Planus, Oral - 10 Studies Found
Status | Study |
Completed |
Study Name: Efficacy of Elidel Cream on Erosive Oral Lichen Planus Condition: Lichen Planus, Oral Date: 2005-08-12 Interventions: Drug: Pimecrolimus |
Completed |
Study Name: Safety and Effectiveness of Efalizumab to Treat Oral Lichen Planus Condition: Lichen Planus, Oral Date: 2005-08-19 Interventions: Drug: efalizumab |
Recruiting |
Study Name: Study of Inflammatory Role of Epstein-Barr Virus (EBV) in Atrophic and Erosive Forms of Oral Lichen Planus Condition: Lichen Planus, Oral Date: 2014-10-24 Interventions: Biological: buccal cavity sample |
Completed |
Study Name: Clinical and Immunohistochemical Effect of Topical Pimecrolimus in Treatment of Oral Lichen Planus Condition: Oral Lichen Planus Date: 2015-05-10 Interventions:
|
Completed |
Study Name: Comparison of Tacrolimus 0.1% and Clobetasol 0.05% in the Management of Symptomatic Oral Lichen Planus Condition: Oral Lichen Planus Date: 2016-04-06 Interventions:
|
Completed |
Study Name: A Clinical Trial to Study the Effects of Two Drugs, Lycopene and Prednisolone in Patients With Oral Lichen Planus Condition: Oral Lichen Planus Date: 2015-10-20 Interventions:
|
Completed |
Study Name: A Randomized Clinical Trial of the Effect of Pimecrolimus Cream 1% Compared With Topical Corticosteroid in Treatment of Erosive Oral Lichen Planus Condition: Oral Lichen Planus Date: 2012-01-31 Interventions:
|
Completed |
Study Name: Cedar Honey in Oral Lichen Planus Condition: Erosive and Atrophic Oral Lichen Planus Date: 2013-10-26 Interventions: Drug: orally administered cedar honey |
Recruiting |
Study Name: Serum Cortisol Levels in Patients With Anxiety and Depression With Symptomatic Oral Lichen Planus Condition: Oral Lichen Planus Related Stress Date: 2017-01-04 Interventions: Procedure: venepuncture for both the groups, HADS questionnaire will be administered to assess the level |
NOT_YET_RECRUITING |
Study Name: Efficacy and Safety of Baricitinib in Oral Lichen Planus: a Proof-of-Concept Study Condition: Lichen Planus, Oral Date: 2024-10-03 Interventions: 4 milligrams once daily |